The Point-Of-Care Diagnostics/Testing (Poct) market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Point-Of-Care Diagnostics/Testing (Poct) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Point-Of-Care Diagnostics/Testing (Poct) market.
Key players in the global Point-Of-Care Diagnostics/Testing (Poct) market covered in Chapter 2 and Chapter 6:
Abbott
Spectral Medical, Inc.
Quidel Corporation
Roche Diagnostics
QIAGEN
Nipro
Becton Dickinson and Company
Abaxis, Inc.
OraSure Technologies Inc.
Nova Biomedical
Johnson and Johnson
Trividia Health, Inc.
bioM?rieux SA
Siemens
Danaher
In Chapter 8 and Chapter 10.3, based on types, the Point-Of-Care Diagnostics/Testing (Poct) market from 2017 to 2029 is primarily split into:
Glucose Testing
Hb1Ac Testing
Coagulation
Fertility
Infectious Diseases
Others
In Chapter 9 and Chapter 10.4, based on applications, the Point-Of-Care Diagnostics/Testing (Poct) market from 2017 to 2029 covers:
Clinics
Hospital
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Point-Of-Care Diagnostics/Testing (Poct) market, containing global revenue and CAGR. The forecast and analysis of Point-Of-Care Diagnostics/Testing (Poct) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Point-Of-Care Diagnostics/Testing (Poct). Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Point-Of-Care Diagnostics/Testing (Poct) industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Point-Of-Care Diagnostics/Testing (Poct) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Point-Of-Care Diagnostics/Testing (Poct) in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Point-Of-Care Diagnostics/Testing (Poct) market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Point-Of-Care Diagnostics/Testing (Poct), by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Point-Of-Care Diagnostics/Testing (Poct) market, including the global sales and revenue forecast, regional forecast. It also foresees the Point-Of-Care Diagnostics/Testing (Poct) market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Point-Of-Care Diagnostics/Testing (Poct) Market Overview
1.1 Product Overview and Scope of Point-Of-Care Diagnostics/Testing (Poct)
1.2 Point-Of-Care Diagnostics/Testing (Poct) Segment by Type
1.2.1 Global Point-Of-Care Diagnostics/Testing (Poct) Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Glucose Testing
1.2.3 The Market Profile of Hb1Ac Testing
1.2.4 The Market Profile of Coagulation
1.2.5 The Market Profile of Fertility
1.2.6 The Market Profile of Infectious Diseases
1.2.7 The Market Profile of Others
1.3 Global Point-Of-Care Diagnostics/Testing (Poct) Segment by Application
1.3.1 Point-Of-Care Diagnostics/Testing (Poct) Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Clinics
1.3.3 The Market Profile of Hospital
1.4 Global Point-Of-Care Diagnostics/Testing (Poct) Market, Region Wise (2017-2022)
1.4.1 Global Point-Of-Care Diagnostics/Testing (Poct) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.3 Europe Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.3.1 Germany Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.3.2 UK Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.3.3 France Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.3.4 Italy Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.3.5 Spain Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.3.6 Russia Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.3.7 Poland Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.4 China Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.5 Japan Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.6 India Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.8 Latin America Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Point-Of-Care Diagnostics/Testing (Poct) Market Status and Prospect (2017-2022)
1.5 Global Market Size of Point-Of-Care Diagnostics/Testing (Poct) (2017-2029)
1.5.1 Global Point-Of-Care Diagnostics/Testing (Poct) Revenue Status and Outlook (2017-2029)
1.5.2 Global Point-Of-Care Diagnostics/Testing (Poct) Sales Status and Outlook (2017-2029)
2 Global Point-Of-Care Diagnostics/Testing (Poct) Market Landscape by Player
2.1 Global Point-Of-Care Diagnostics/Testing (Poct) Sales and Share by Player (2017-2022)
2.2 Global Point-Of-Care Diagnostics/Testing (Poct) Revenue and Market Share by Player (2017-2022)
2.3 Global Point-Of-Care Diagnostics/Testing (Poct) Average Price by Player (2017-2022)
2.4 Global Point-Of-Care Diagnostics/Testing (Poct) Gross Margin by Player (2017-2022)
2.5 Point-Of-Care Diagnostics/Testing (Poct) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Point-Of-Care Diagnostics/Testing (Poct) Market Competitive Situation and Trends
2.6.1 Point-Of-Care Diagnostics/Testing (Poct) Market Concentration Rate
2.6.2 Point-Of-Care Diagnostics/Testing (Poct) Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Point-Of-Care Diagnostics/Testing (Poct) Upstream and Downstream Analysis
3.1 Point-Of-Care Diagnostics/Testing (Poct) Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Point-Of-Care Diagnostics/Testing (Poct) Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Point-Of-Care Diagnostics/Testing (Poct) Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Point-Of-Care Diagnostics/Testing (Poct) Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Point-Of-Care Diagnostics/Testing (Poct)
5.3.2 Increased Demand in Emerging Markets
5.4 Point-Of-Care Diagnostics/Testing (Poct) Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Point-Of-Care Diagnostics/Testing (Poct) Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Abbott
6.1.1 Abbott Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.1.3 Abbott Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.1.4 Abbott Business Overview
6.2 Spectral Medical, Inc.
6.2.1 Spectral Medical, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.2.3 Spectral Medical, Inc. Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.2.4 Spectral Medical, Inc. Business Overview
6.3 Quidel Corporation
6.3.1 Quidel Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.3.3 Quidel Corporation Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.3.4 Quidel Corporation Business Overview
6.4 Roche Diagnostics
6.4.1 Roche Diagnostics Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.4.3 Roche Diagnostics Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.4.4 Roche Diagnostics Business Overview
6.5 QIAGEN
6.5.1 QIAGEN Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.5.3 QIAGEN Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.5.4 QIAGEN Business Overview
6.6 Nipro
6.6.1 Nipro Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.6.3 Nipro Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.6.4 Nipro Business Overview
6.7 Becton Dickinson and Company
6.7.1 Becton Dickinson and Company Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.7.3 Becton Dickinson and Company Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.7.4 Becton Dickinson and Company Business Overview
6.8 Abaxis, Inc.
6.8.1 Abaxis, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.8.3 Abaxis, Inc. Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.8.4 Abaxis, Inc. Business Overview
6.9 OraSure Technologies Inc.
6.9.1 OraSure Technologies Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.9.3 OraSure Technologies Inc. Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.9.4 OraSure Technologies Inc. Business Overview
6.10 Nova Biomedical
6.10.1 Nova Biomedical Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.10.3 Nova Biomedical Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.10.4 Nova Biomedical Business Overview
6.11 Johnson and Johnson
6.11.1 Johnson and Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
6.11.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.11.3 Johnson and Johnson Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.11.4 Johnson and Johnson Business Overview
6.12 Trividia Health, Inc.
6.12.1 Trividia Health, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.12.2 Point-Of-Care Diagnostics/Testing (Poct) Product Profiles, Application and Specification
6.12.3 Trividia Health, Inc. Point-Of-Care Diagnostics/Testing (Poct) Market Performance (2017-2022)
6.12.4 Trividia Health, Inc. Business Overview
6.13 bioM